Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy

Taylor, A orcid.org/0000-0003-2295-2611 and Rudd, CE (2019) Commentary: Small Molecule Inhibition of PD-1 Transcription is an Effective Alternative to Antibody Blockade in Cancer Therapy. Journal of Immunological Sciences, 3 (1). pp. 9-12. ISSN 2578-3009

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: ©2019 Taylor A. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License.(http://creativecommons.org/licenses/by/4.0/).
Keywords: Nivolumab; Pembrolizumab
Dates:
  • Accepted: 16 February 2019
  • Published (online): 16 February 2019
  • Published: May 2019
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cancer and Pathology (LICAP) > Infection and Immunity (Leeds)
Funding Information:
FunderGrant number
Cancer Research UKC11071/A20105
Depositing User: Symplectic Publications
Date Deposited: 01 Jul 2019 09:58
Last Modified: 01 Jul 2019 09:59
Status: Published
Publisher: Journal of Immunological Sciences
Identification Number: https://doi.org/10.29245/2578-3009/2019/1.1167
Related URLs:

Export

Statistics


CORE (COnnecting REpositories)